A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

October 31, 2008

Conditions

Diabetes MellitusHealthy Subjects

Interventions

DRUG

Technosphere Insulin (TI) Inhalation Powder

3.0 U of human insulin. 5 or 10 mg or Technosphere Inhalation Powder, containing 15 0r 30 U of insulin.

DRUG

Albuterol (Salbutamol)

2 puff= 200ug total dose

DRUG

Fluticasone

2 puffs= 500ug total dose

Trial Locations (1)

ICON Development Solutions, Manchester, United Kingdom